City State Bank Decreases Stake in CVS Health Co. (NYSE:CVS)

City State Bank trimmed its holdings in shares of CVS Health Co. (NYSE:CVSGet Rating) by 21.5% during the fourth quarter, Holdings Channel reports. The fund owned 4,007 shares of the pharmacy operator’s stock after selling 1,100 shares during the quarter. City State Bank’s holdings in CVS Health were worth $373,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of CVS. SRS Capital Advisors Inc. raised its position in shares of CVS Health by 105.8% in the 3rd quarter. SRS Capital Advisors Inc. now owns 284 shares of the pharmacy operator’s stock valued at $27,000 after purchasing an additional 146 shares in the last quarter. Karp Capital Management Corp acquired a new stake in CVS Health in the third quarter valued at $30,000. EWG Elevate Inc. bought a new position in CVS Health during the 4th quarter valued at $32,000. Coston McIsaac & Partners acquired a new position in CVS Health during the 2nd quarter worth $34,000. Finally, Moisand Fitzgerald Tamayo LLC increased its position in shares of CVS Health by 63.6% in the 3rd quarter. Moisand Fitzgerald Tamayo LLC now owns 368 shares of the pharmacy operator’s stock worth $35,000 after purchasing an additional 143 shares during the last quarter. Hedge funds and other institutional investors own 77.29% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently commented on CVS shares. Credit Suisse Group lifted their price target on CVS Health from $117.00 to $125.00 and gave the stock an “outperform” rating in a research note on Monday, November 21st. Royal Bank of Canada reiterated an “outperform” rating and issued a $115.00 price target on shares of CVS Health in a report on Thursday, February 9th. TheStreet upgraded CVS Health from a “c+” rating to a “b” rating in a research note on Friday, November 25th. Jefferies Financial Group boosted their target price on shares of CVS Health from $130.00 to $143.00 and gave the company a “buy” rating in a research note on Thursday, February 9th. Finally, Raymond James reduced their price target on shares of CVS Health from $115.00 to $110.00 and set an “outperform” rating on the stock in a research report on Thursday, February 9th. Three analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. According to MarketBeat, CVS Health currently has an average rating of “Moderate Buy” and an average price target of $119.65.

CVS Health Stock Performance

Shares of CVS traded down $1.46 during mid-day trading on Friday, reaching $74.37. 16,807,803 shares of the company’s stock traded hands, compared to its average volume of 7,963,418. CVS Health Co. has a 12 month low of $73.91 and a 12 month high of $109.69. The stock has a market capitalization of $95.50 billion, a P/E ratio of 23.84, a price-to-earnings-growth ratio of 1.17 and a beta of 0.65. The business’s 50-day moving average price is $85.40 and its 200-day moving average price is $93.00. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.67 and a current ratio of 0.94.

CVS Health (NYSE:CVSGet Rating) last announced its earnings results on Wednesday, February 8th. The pharmacy operator reported $1.99 earnings per share for the quarter, beating the consensus estimate of $1.92 by $0.07. CVS Health had a return on equity of 15.75% and a net margin of 1.29%. The firm had revenue of $83.85 billion for the quarter, compared to the consensus estimate of $76.37 billion. During the same quarter in the previous year, the business earned $1.98 EPS. The firm’s revenue for the quarter was up 9.5% on a year-over-year basis. Equities analysts predict that CVS Health Co. will post 8.84 earnings per share for the current year.

CVS Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, May 1st. Shareholders of record on Friday, April 21st will be paid a dividend of $0.605 per share. The ex-dividend date of this dividend is Thursday, April 20th. This represents a $2.42 annualized dividend and a yield of 3.25%. CVS Health’s payout ratio is 77.56%.

CVS Health Profile

(Get Rating)

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Pharmacy Services, Retail or Long-Term Care, Health Care Benefits, and Corporate and Other. The Pharmacy Services segment focuses on the pharmacy benefit management solutions.

See Also

Want to see what other hedge funds are holding CVS? Visit to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVSGet Rating).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with's FREE daily email newsletter.